Etiqueta: Distrofia Muscular
Piden acelerar la aprobacion de nuevo medicamento de San Diego para distrofia muscular (inglés)
Shares of drugmaker aTyr Pharma climbed over 30 percent Wednesday following news that the San Diego firm’s drug should progress quickly through the regulatory process.
ATyr’s drug, called Resolaris, was granted “fast-track” status by the...